Litkouhi et al. reported that CEACAM6 is expressed at higher levels in borderline mucinous neoplasms and invasive mucinous carcinomas than in serous ovarian neoplasms [29]. The gene discussed is CEACAM6; the disease is ovarian serous tumor.